20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
Ref.: C.L.22.2019
Entry into force of an amendment to the International Health Regulations (2005), and
publication of the Third Edition of International Health Regulations (2005) booklet
The Director-General of the World Health Organization (WHO) presents his
compliments to States Parties to the International Health Regulations (2005) (IHR (2005)) and
... has the honour to refer to C.L.20.2016 and resolution WHA67.13 (copy enclosed) by which the
Sixty-seventh World Health Assembly adopted an amendment to update Annex 7 of the
IHR (2005).
... The amended Annex 7 of IHR (2005) (copy enclosed) entered into force and is legally
binding upon all States Parties from 11 July 2016. No State Party submitted a rejection or
reservation to the amendment within the required period for such submissions, which expired in
January 2016.
In the context of international travel, the amended Annex 7 extends the period of validity
of an IHR (2005) international certificate of vaccination against yellow fever, and the protection
provided by vaccination against yellow fever infection, from ten years to the life of the person
(traveller) vaccinated. Accordingly, following entry into force of the amendment on
11 July 2016, for both existing or new certificates, revaccination or a booster dose of yellow
fever vaccine cannot be required of international travellers as a condition of entry into a State
Party, regardless of the date their international certificate of vaccination was initially issued.
The Director-General brings to the attention of States Parties the need to ensure that all
relevant personnel are informed and prepared, and that all necessary updating of related
regulations, procedures and policies is carried out so that the new requirements are
implemented fully.
The revised Third Edition of the IHR (2005) is available on the WHO website at:
https://www.who.int/ihr/publications/9789241580496/en/.
The Director-General of the World Health Organization takes this opportunity to renew
to States Parties to the International Health Regulations (2005) the assurance of his highest
consideration.
Geneva, 8 April 2019
... ENCLS.: (2)
WHA67.13 Implementation of the International Health Regulations (2005)
The Sixty-seventh World Health Assembly,
Having considered the report on implementation of the International Health Regulations (2005); 1
Recalling the recent meeting and report of the Strategic Advisory Group of Experts on immunization, 2
which completed its scientific review and analysis of evidence on issues concerning vaccination against yellow
fever and concluded that a single dose of yellow fever vaccine is sufficient to confer sustained immunity and
life-long protection against yellow fever disease, and that a booster dose of yellow fever vaccine is not needed;
Noting that in its report the Strategic Advisory Group of Experts on immunization recommended
that WHO should revisit the provisions in the International Health Regulations (2005) relating to the period
of validity for international certificates for vaccination against yellow fever,
ADOPTS, in accordance with paragraph 3 of Article 55 of the International Health Regulations (2005),
the updated Annex 7 of the International Health Regulations (2005).
(Ninth plenary meeting, 24 May 2014 –
Committee A, sixth report)
_______________
1 Document A67/35.
2 Meeting of the Strategic Advisory Group of Experts on immunization, April 2013 – conclusions and recommendations.
Weekly epidemiological record. 2013;88(20):201–216.
Text of the updated Annex 7 of the
International Health Regulations (2005) 1
[A67/35 – 2 May 2014]
REQUIREMENTS CONCERNING VACCINATION OR
PROPHYLAXIS FOR SPECIFIC DISEASES
1. In addition to any recommendation concerning vaccination or prophylaxis, the following diseases are
those specifically designated under these Regulations for which proof of vaccination or prophylaxis may be
required for travellers as a condition of entry to a State Party:
Vaccination against yellow fever.
2. Recommendations and requirements for vaccination against yellow fever:
(a) For the purpose of this Annex:
(i) the incubation period of yellow fever is six days;
(ii) yellow fever vaccines approved by WHO provide protection against infection starting
10 days following the administration of the vaccine;
(iii) this protection continues for the life of the person vaccinated; and
(iv) the validity of a certificate of vaccination against yellow fever shall extend for the life of
the person vaccinated, beginning 10 days after the date of vaccination.
(b) Vaccination against yellow fever may be required of any traveller leaving an area where the
Organization has determined that a risk of yellow fever transmission is present.
(c) If a traveller is in possession of a certificate of vaccination against yellow fever which is not yet
valid, the traveller may be permitted to depart, but the provisions of paragraph 2(h) of this Annex may
be applied on arrival.
(d) A traveller in possession of a valid certificate of vaccination against yellow fever shall not be
treated as suspect, even if coming from an area where the Organization has determined that a risk of
yellow fever transmission is present.
(e) In accordance with paragraph 1 of Annex 6 the yellow fever vaccine used must be approved by
the Organization.
(f) States Parties shall designate specific yellow fever vaccination centres within their territories in
order to ensure the quality and safety of the procedures and materials employed.
1 See resolution WHA67.13.
(g) Every person employed at a point of entry in an area where the Organization has determined that
a risk of yellow fever transmission is present, and every member of the crew of a conveyance using any
such point of entry, shall be in possession of a valid certificate of vaccination against yellow fever.
(h) A State Party, in whose territory vectors of yellow fever are present, may require a traveller from
an area where the Organization has determined that a risk of yellow fever transmission is present, who is
unable to produce a valid certificate of vaccination against yellow fever, to be quarantined until the
certificate becomes valid, or until a period of not more than six days, reckoned from the date of last possible
exposure to infection, has elapsed, whichever occurs first.
(i) Travellers who possess an exemption from yellow fever vaccination, signed by an authorized
medical officer or an authorized health worker, may nevertheless be allowed entry, subject to the
provisions of the foregoing paragraph of this Annex and to being provided with information regarding
protection from yellow fever vectors. Should the travellers not be quarantined, they may be required to
report any feverish or other symptoms to the competent authority and be placed under surveillance.
_______________
Saatja: <
[email protected]>
Saadetud: 10.04.2019 13:11
Koopia: <
[email protected]>
Teema: WHO: C.L.22.2019 (IHR (2005))
Manused: C.L.22.2019 (IHR (2005)).pdf; C.L.22.2019 Arabic.pdf; C.L.22.2019 Chinese.pdf;
C.L.22.2019 French.pdf; C.L.22.2019 Russian.pdf; C.L.22.2019 Spanish.pdf
Dear Member States of the World Health Organization,
Please find attached, in the six official languages, C.L.22.2019.
Should you have any question regarding C.L.22.2019 please send an email to
[email protected]
Best regards,
Department of Governing Bodies
World Health Organization